Table 5.

Comparison of the immune function of the included patients between the two groups ($\overline{x}\pm s$).

Group	Group A (n = 43)	Group B (n = 43)
CD3+
Before intervention	61.05 ± 7.36	61.01 ± 8.23
1 d after intervention	48.06 ± 9.13^	50.14 ± 12.52^
3 d after intervention	57.06 ± 8.05^	59.14 ± 10.38
CD4+
Before intervention	37.07 ± 4.24	37.64 ± 4.18
1 d after intervention	27.18 ± 6.33^	29.25 ± 7.61^
3 d after intervention	34.18 ± 5.19^	35.75 ± 5.64
CD8+
Before intervention	25.05 ± 2.68	24.07 ± 3.05
1 d after intervention	20.60 ± 3.17^	20.41 ± 2.32^
3 d after intervention	23.60 ± 3.35^	23.41 ± 2.61
CD4+/CD8+
Before intervention	1.66 ± 0.13	1.63 ± 0.14
1 d after intervention	1.38 ± 0.15^	1.37 ± 0.25^
3 d after intervention	1.48 ± 0.17^	1.57 ± 0.16∗

Note: compared with the control group, ^∗P < 0.05; compared with before treatment, ^{^}P < 0.05.